Description: This panel will discuss various product issues relating to dread disease products: features, cost levels, evolution, the future, the consumer and regulatory environment, and payroll deductions. The panel will describe the current products available in this market, with emphasis on cancer insurance. From the Record of the Society of Actuaries, Vol. 21, No. 4a.

Description: In session 7I of the Montreal Spring Meeting panelists discuss the growth of the cross-selling of financial products in the banking and insurance sectors. From the Record of the Society of Actuaries, Vol. 23, No. 2.

Description: This session from the 1984 SOA Salt Lake City Meeting discusses the latest Exposure Draft of the Committee on Theory of Dividends and other Non-Guaranteed Elements in Life Insurance and Annuities and of other related developments in this area.

Description: Presented at June 1986 Spring Meeting. This session discussion is about historical perspective on guaranty funds, recently activated state guaranty funds, what alternatives are available, what could cause the system to break down, and should guarantee funds exist.

Description: This paper investigates the implications of using the Basel II motivated Advanced Measurement Approaches as a method to assess operational risk capital charges for banks and insurance companies with regard to U.S. regulations. The AMA developed in the paper uses actuarial loss models complemented by the extreme value theory to determine the empirical probability distribution function of the aggregated capital charges in the context of various classes of copulas. From Actuarial Research Clearing House, 2006.

Description: An overview of health care history and privatization developments in four Latin American countries: Mexico, Chile, Colombia, and Brazil.

Description: Overview of Solvency II regulations in the EU and potential impacts on U.S.-domiciled companies.

Description: This article reviews some of the highlights of th 2010 SOA Annual meeting including the impact on pricing resulting from Solvency II, Market Consistent Valuation of New Business - MCVNB, the latest on mortality, Standards of Practice in product development, managing risk in product design and a regulation update.

Description: The crisis has spread due to a systematic failure of the regulatory system. Over the last 20 years, regulations that fostered market stability were eliminated and new financial instruments were allowed to propagate without any real oversight. Instead of bailing out weak financial firms, we should be liquidating them. All doubtful assets need to be written-downs. We need accurate and transparent accounting. Government can help in this effort by cleaning up our accounting system. But it needs to stop being an investor propping up those that should be in the morgue. It needs to conservatively regulate all financial instruments. It should foster liquidity and stoke demand.

Description: The author summarizes certain presentations at the ERM II Systemic Risk Workshop. The key objective of the workshop was to develop recommendations that could serve as input to regulators, legislators and other policy makers in designing and implementing systemic risk regulation that can prevent future financial crises.